MENU
KYMR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kymera Therapeutics (KYMR) Ownership - Who owns Kymera Therapeutics?
Profile
Industry
N/A
Address
200 Arsenal Yards Boulevard
Phone
+1 857 285-5300
Employees
187
Web
https://www.kymeratx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.15B
P/E Ratio
N/A
Total Cash
549.97M
Projected Growth
N/A
Total Debt
88.23M
Revenue
87.56M
Risk (Beta)
2.49
Dividend Yield
N/A
Total Cash/Share
8.49
Total Debt/Equity
N/A
Revenue/Share
1.26 USD as % of share price
Fundamentals
KYMR
Capitalization
3.15B
P/E Ratio
N/A
Risk (Beta)
2.49
Dividend Yield
N/A
Total Cash
550M
Total Cash/Share
8.49
Total Debt
88.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.26%
Revenue
87.6M
ROE
N/A
Book Value
893M
P/B Ratio
3.53
Cash Flow
N/A
Earnings
-2.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
8.55
Current Revenue Per Employee
20331.52
Dividends Per Share - Security
N/A
EBITDA
-160.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.10
Shares Held By Institutions
3.16B
Shares Outstanding - Current
64.8M
Total Liabilities
142M
Total Volume MTD
N/A
Value
-1
Gain YTD
91.006
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
200 Arsenal Yards Boulevard
Phone
+1 857 285-5300
Employees
187
Web
https://www.kymeratx.com